Review of Strategic Shareholdings Held to Maintain Business Relationships
First written in FY2019. 3 of 8 entries say "Restated". Latest entry: FY2026.
49 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Based on the above, at a Board of Directors meeting held on 31 March 2026, we reviewed whether it was appropriate to continue holding the listed shares held as of the end of February 2026.」
The policy of not holding investment shares except where necessary, together with the annual review of holding appropriateness by the Board of Directors, has continued. - FY2025Partial sale of cross-shareholdingsAnnual report
「We sold part of certain shareholdings during the fiscal year.」
The annual review of holding appropriateness by the Board of Directors has continued, and part of 1 issue of listed shares was sold during the fiscal year. - FY2024RestatedAnnual report
「Based on the above, at a Board of Directors meeting held on 31 March 2024, we reviewed whether it was appropriate to continue holding the listed shares held as of the end of February 2024.」
The policy of not holding investment shares except where necessary, together with the annual review of holding appropriateness by the Board of Directors, has continued. - FY2023Continued review of cross-shareholdings and sale of sharesAnnual report
「Based on the above, at a Board of Directors meeting held on 31 March 2023, we reviewed whether it was appropriate to continue holding the listed shares held as of the end of February 2023.」
The annual review of holding appropriateness by the Board of Directors has continued, and 1 issue of unlisted shares was sold for ¥516 million during the fiscal year. - FY2022Review of cross-shareholdings and sale of 1 issueAnnual report
「Based on the above, at a Board of Directors meeting held on 31 March 2022, we reviewed whether it was appropriate to continue holding the listed shares held as of the end of February 2022.」
The policy of not holding investment shares except where necessary and the annual Board of Directors review have continued, and shares of Ezaki Glico were sold during the fiscal year. - FY2021RestatedAnnual report
「For each individual cross-shareholding, the Board of Directors reviews the purpose of the holding, the status of transactions and other matters each year, and verifies whether the holding remains appropriate.」
The policy of not holding investment shares except where necessary, together with the annual review of holding appropriateness by the Board of Directors, has continued. - FY2020SoftenedAnnual report
「As a basic policy, we do not hold investment shares except where necessary to maintain or strengthen relationships with investees, from the perspectives of avoiding the risks of shareholdings and improving asset efficiency.」
The policy has been narrowed from holding shares premised on maintaining business relationships to not holding them except where necessary, with the Board of Directors reviewing the appropriateness of each holding annually. - FY2019First statedAnnual report
「We hold shares for business policy purposes, premised on maintaining good business relationships. For all shares held, the Board of Directors reviews each year, on an issue-by-issue basis, the rationale for the holding purpose and the related revenue and benefits from holding the shares, and determines whether to continue holding them.」
The policy of holding shares of business partners for business policy purposes and having the Board of Directors review the rationale, related revenue and benefits for each issue annually is recorded as a thread for the first time.